Igm Biosciences, Inc.
Igm Biosciences, Inc. lobbies on its own behalf. For Q4 2024 it reported $0 across 1 client report and lists 1 lobbyist across its filings.
Clients, Q4 2024
By year
Lobbyists listed
Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.
